These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 22051059)

  • 1. Effects of losartan on whole body, skeletal muscle and vascular insulin responses in obesity/insulin resistance without hypertension.
    Lteif AA; Chisholm RL; Gilbert K; Considine RV; Mather KJ
    Diabetes Obes Metab; 2012 Mar; 14(3):254-61. PubMed ID: 22051059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-induced vasodilatation and endothelial function in obesity/insulin resistance. Effects of troglitazone.
    Tack CJ; Ong MK; Lutterman JA; Smits P
    Diabetologia; 1998 May; 41(5):569-76. PubMed ID: 9628275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved insulin sensitivity with the angiotensin II-receptor blocker losartan in patients with hypertension and other cardiovascular risk factors.
    Aksnes TA; Reims HM; Guptha S; Moan A; Os I; Kjeldsen SE
    J Hum Hypertens; 2006 Nov; 20(11):860-6. PubMed ID: 16988754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of angiotensin receptor blockade on insulin sensitivity and endothelial function in abdominally obese hypertensive patients with impaired fasting glucose.
    Perlstein TS; Henry RR; Mather KJ; Rickels MR; Abate NI; Grundy SM; Mai Y; Albu JB; Marks JB; Pool JL; Creager MA
    Clin Sci (Lond); 2012 Feb; 122(4):193-202. PubMed ID: 21861845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Losartan increases muscle insulin delivery and rescues insulin's metabolic action during lipid infusion via microvascular recruitment.
    Wang N; Chai W; Zhao L; Tao L; Cao W; Liu Z
    Am J Physiol Endocrinol Metab; 2013 Mar; 304(5):E538-45. PubMed ID: 23299501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effects of lisinopril and losartan on insulin sensitivity in the treatment of non diabetic hypertensive patients.
    Fogari R; Zoppi A; Corradi L; Lazzari P; Mugellini A; Lusardi P
    Br J Clin Pharmacol; 1998 Nov; 46(5):467-71. PubMed ID: 9833600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance of glucose uptake in skeletal muscle cannot be ameliorated by enhancing endothelium-dependent blood flow in obesity.
    Laine H; Yki-Jarvinen H; Kirvela O; Tolvanen T; Raitakari M; Solin O; Haaparanta M; Knuuti J; Nuutila P
    J Clin Invest; 1998 Mar; 101(5):1156-62. PubMed ID: 9486987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Losartan modifies glomerular hyperfiltration and insulin sensitivity in type 1 diabetes.
    Nielsen S; Hove KY; Dollerup J; Poulsen PL; Christiansen JS; Schmitz O; Mogensen CE
    Diabetes Obes Metab; 2001 Dec; 3(6):463-71. PubMed ID: 11903420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute, local infusion of angiotensin II impairs microvascular and metabolic insulin sensitivity in skeletal muscle.
    Premilovac D; Attrill E; Rattigan S; Richards SM; Kim J; Keske MA
    Cardiovasc Res; 2019 Mar; 115(3):590-601. PubMed ID: 30192915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blockade of the Renin-Angiotensin system improves insulin receptor signaling and insulin-stimulated skeletal muscle glucose transport in burn injury.
    Kasper SO; Phillips EE; Castle SM; Daley BJ; Enderson BL; Karlstad MD
    Shock; 2011 Jan; 35(1):80-5. PubMed ID: 20823693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Losartan improves aortic endothelium-dependent relaxation via proline-rich tyrosine kinase 2/Src/Akt pathway in type 2 diabetic Goto-Kakizaki rats.
    Nemoto S; Kobayashi T; Taguchi K; Matsumoto T; Kamata K
    Am J Physiol Heart Circ Physiol; 2011 Dec; 301(6):H2383-94. PubMed ID: 21926342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of fructose-induced hypertension and insulin resistance by chronic losartan treatment is independent of AT2 receptor activation in rats.
    Hsieh PS
    J Hypertens; 2005 Dec; 23(12):2209-17. PubMed ID: 16269963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperinsulinemic rats are normotensive but sensitized to angiotensin II.
    Johansson ME; Andersson IJ; Alexanderson C; Skøtt O; Holmäng A; Bergström G
    Am J Physiol Regul Integr Comp Physiol; 2008 Apr; 294(4):R1240-7. PubMed ID: 18216141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrasting effects of L-arginine on insulin-mediated blood flow and glucose disposal in the elderly.
    Meneilly GS; Battistini B; Floras JS
    Metabolism; 2001 Feb; 50(2):194-9. PubMed ID: 11229429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of angiotensin II-receptor blockade with losartan on insulin sensitivity, lipid profile, and endothelin in normotensive offspring of hypertensive parents.
    Lerch M; Teuscher AU; Beissner P; Schneider M; Shaw SG; Weidmann P
    J Cardiovasc Pharmacol; 1998 Apr; 31(4):576-80. PubMed ID: 9554807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelin limits insulin action in obese/insulin-resistant humans.
    Lteif A; Vaishnava P; Baron AD; Mather KJ
    Diabetes; 2007 Mar; 56(3):728-34. PubMed ID: 17327443
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of ACE inhibition and AT1-receptor antagonism on endothelial function and insulin sensitivity in essential hypertensive patients.
    Yavuz D; Koç M; Toprak A; Akpinar I; Velioğlu A; Deyneli O; Haklar G; Akalin S
    J Renin Angiotensin Aldosterone Syst; 2003 Sep; 4(3):197-203. PubMed ID: 14608527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance.
    Steinberg HO; Chaker H; Leaming R; Johnson A; Brechtel G; Baron AD
    J Clin Invest; 1996 Jun; 97(11):2601-10. PubMed ID: 8647954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of effect of sodium nitroprusside on insulin-mediated blood flow and glucose disposal in the elderly.
    Meneilly GS; Battistini B; Floras JS
    Metabolism; 2000 Mar; 49(3):373-8. PubMed ID: 10726917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heterogeneity in insulin-stimulated glucose uptake among different muscle groups in healthy lean people and people with obesity.
    Koh HE; van Vliet S; Meyer GA; Laforest R; Gropler RJ; Klein S; Mittendorfer B
    Diabetologia; 2021 May; 64(5):1158-1168. PubMed ID: 33511440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.